Unseen costs of prior authorization

Prior authorizations are often used as a cost containment tactic by payers — and it works in reducing the amount that the payer must pay for the PA drug (i.e. in financial terms, the line item goes down).

However, decreases in the line item are showing up somewhere else.

At a study conducted at the University of Alabama at Birmingham HIV/AIDS outpatient clinic, the PA process imposes uncompensated costs to medical providers. The study found that the overall cost was $41.60 per PA.

Additionally, the researcher concluded the PA process “significantly delays medication accessibility for patients and imposes high costs that negatively impact operating margins for health care providers”.

Yes, payers need to make a profit — they are businesses after all — but, what’s the answer?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: